ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Disease
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy

Asthma trials near Charlotte, NC, USA:

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...

Enrolling
Severe Asthma
Drug: Placebo
Drug: GB-0895

Phase 3

Generate Biomedicines

Gastonia, North Carolina, United States and 109 other locations

The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...

Enrolling
Severe Asthma
Drug: GB-0895
Drug: Placebo

Phase 3

Generate Biomedicines

Rock Hill, South Carolina, United States and 106 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Charlotte, North Carolina, United States and 335 other locations

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...

Active, not recruiting
Asthma
Biological: NSI-8226
Biological: Placebo

Phase 2

Uniquity One (UNI)

Gastonia, North Carolina, United States of America and 70 other locations

Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...

Enrolling
Severe Asthma
Drug: Placebo
Drug: Frevecitinib

Phase 2

Kinaset Therapeutics

Charlotte, North Carolina, United States and 14 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Charlotte, North Carolina, United States of America and 136 other locations

trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Drug: Inhaled corticosteroids/long-acting beta-2 agonists

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Charlotte, North Carolina, United States and 116 other locations

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Active, not recruiting
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

Phase 2

Incyte
Incyte

Charlotte, North Carolina, United States and 83 other locations

of AMG 691 as single doses (healthy participants only) and multiple doses in healthy participants and participants with mild-to-moderate asthma...

Active, not recruiting
Asthma
Drug: Placebo
Drug: AMG 691

Phase 1

Amgen
Amgen

Monroe, North Carolina, United States of America and 20 other locations

This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...

Enrolling
Eosinophilic Asthma
Drug: KT-621
Other: Placebo

Phase 2

Kymera Therapeutics

Rock Hill, South Carolina, United States and 70 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems